Novo Nordisk invests $2.3b in France for diabetes, obesity drugs
HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..
Drugs
Health
Pharma